CytomX Therapeutics (CTMX) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 2.20 -0.12 (5.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.32 | 52 Week High | $24.68 | |||
| Open | $2.31 | 52 Week Low | $9.10 | |||
| Day High | $2.33 | P/E | N/A | |||
| Day Low | $2.19 | EPS | $0.00 | |||
| Volume | 880,202 | |||||
